These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 28214140)

  • 1. A review of strategies for infarct size reduction during acute myocardial infarction.
    Parviz Y; Vijayan S; Lavi S
    Cardiovasc Revasc Med; 2017; 18(5):374-383. PubMed ID: 28214140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reperfusion strategies in acute coronary syndromes.
    Bagai A; Dangas GD; Stone GW; Granger CB
    Circ Res; 2014 Jun; 114(12):1918-28. PubMed ID: 24902975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The reduction of infarct size--forty years of research.
    Ferreira R
    Rev Port Cardiol; 2010 Jun; 29(6):1037-53. PubMed ID: 20964114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
    Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
    Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of time to treatment on myocardial reperfusion and infarct size with primary percutaneous coronary intervention for acute myocardial infarction (from the EMERALD Trial).
    Brodie BR; Webb J; Cox DA; Qureshi M; Kalynych A; Turco M; Schultheiss HP; Dulas D; Rutherford B; Antoniucci D; Stuckey T; Krucoff M; Gibbons R; Lansky A; Na Y; Mehran R; Stone GW;
    Am J Cardiol; 2007 Jun; 99(12):1680-6. PubMed ID: 17560875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infarct Size, Shock, and Heart Failure: Does Reperfusion Strategy Matter in Early Presenting Patients With ST-Segment Elevation Myocardial Infarction?
    Shavadia J; Zheng Y; Dianati Maleki N; Huber K; Halvorsen S; Goldstein P; Gershlick AH; Wilcox R; Van de Werf F; Armstrong PW
    J Am Heart Assoc; 2015 Aug; 4(8):e002049. PubMed ID: 26304934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge.
    Heusch G; Gersh BJ
    Eur Heart J; 2017 Mar; 38(11):774-784. PubMed ID: 27354052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PICSO: from myocardial salvage to tissue regeneration.
    Mohl W; Gangl C; Jusić A; Aschacher T; De Jonge M; Rattay F
    Cardiovasc Revasc Med; 2015; 16(1):36-46. PubMed ID: 25616738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and molecular approaches to enhance myocardial recovery after myocardial infarction.
    Parviz Y; Waleed M; Vijayan S; Adlam D; Lavi S; Al Nooryani A; Iqbal J; Stone GW
    Cardiovasc Revasc Med; 2019 Apr; 20(4):351-364. PubMed ID: 29958820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.
    Woo JS; Kim W; Ha SJ; Kim JB; Kim SJ; Kim WS; Seon HJ; Kim KS
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2252-60. PubMed ID: 23868944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].
    Lupi Herrera E; Gaspar J; González Pacheco H; Martínez Sánchez C; Pastelín Hernández G; Luna Ortiz P; Chávez Cosio E
    Arch Cardiol Mex; 2006; 76 Suppl 4():S76-101. PubMed ID: 17469337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent association between symptom onset time and infarct size in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Mahmoud KD; Nijsten MW; Wieringa WG; Ottervanger JP; Holmes DR; Hillege HL; van 't Hof AW; Lipsic E
    Chronobiol Int; 2015 May; 32(4):468-77. PubMed ID: 25524145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotection: Where to from here?
    Kloner RA; Hale SL; Dai W; Shi J
    Cardiovasc Drugs Ther; 2017 Feb; 31(1):53-61. PubMed ID: 27714476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial.
    Patel MR; Worthley SG; Stebbins A; Dill T; Rademakers FE; Valeti US; Barsness GW; Van de Werf F; Hamm CW; Armstrong PW; Granger CB; Kim RJ
    JACC Cardiovasc Imaging; 2010 Jan; 3(1):52-60. PubMed ID: 20129531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanical Pre-Conditioning With Acute Circulatory Support Before Reperfusion Limits Infarct Size in Acute Myocardial Infarction.
    Kapur NK; Qiao X; Paruchuri V; Morine KJ; Syed W; Dow S; Shah N; Pandian N; Karas RH
    JACC Heart Fail; 2015 Nov; 3(11):873-82. PubMed ID: 26541785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized evaluation of the effects of filter-based distal protection on myocardial perfusion and infarct size after primary percutaneous catheter intervention in myocardial infarction with and without ST-segment elevation.
    Gick M; Jander N; Bestehorn HP; Kienzle RP; Ferenc M; Werner K; Comberg T; Peitz K; Zohlnhöfer D; Bassignana V; Buettner HJ; Neumann FJ
    Circulation; 2005 Sep; 112(10):1462-9. PubMed ID: 16129793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits of reperfusion beyond infarct size limitation.
    Takemura G; Nakagawa M; Kanamori H; Minatoguchi S; Fujiwara H
    Cardiovasc Res; 2009 Jul; 83(2):269-76. PubMed ID: 19176600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of myocardial salvage during acute myocardial infarction: evaluation with a combined angiographic and CMR myocardial salvage index.
    Ortiz-Pérez JT; Lee DC; Meyers SN; Davidson CJ; Bonow RO; Wu E
    JACC Cardiovasc Imaging; 2010 May; 3(5):491-500. PubMed ID: 20466344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The late open artery hypothesis at the crossroad. The ACTOR study: aggressive versus conservative treatment of the infarct-related artery after acute MI. ACTOR Study Group.
    G Ital Cardiol; 1999 Jan; 29(1):1-10. PubMed ID: 9987041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid endovascular catheter core cooling combined with cold saline as an adjunct to percutaneous coronary intervention for the treatment of acute myocardial infarction. The CHILL-MI trial: a randomized controlled study of the use of central venous catheter core cooling combined with cold saline as an adjunct to percutaneous coronary intervention for the treatment of acute myocardial infarction.
    Erlinge D; Götberg M; Lang I; Holzer M; Noc M; Clemmensen P; Jensen U; Metzler B; James S; Bötker HE; Omerovic E; Engblom H; Carlsson M; Arheden H; Ostlund O; Wallentin L; Harnek J; Olivecrona GK
    J Am Coll Cardiol; 2014 May; 63(18):1857-65. PubMed ID: 24509284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.